SARS-CoV-2 Spike-ACE2 Inhibitor Screening Service | Reaction Biology
Frontiers | Angiotensin-Converting Enzyme 2 (ACE2) in the Pathogenesis of ARDS in COVID-19
Deep Mutational Scanning of SARS-CoV-2 Receptor Binding Domain Reveals Constraints on Folding and ACE2 Binding - ScienceDirect
Engineering human ACE2 to optimize binding to the spike protein of SARS coronavirus 2 | Science
Frontiers | ACE2 Shedding and the Role in COVID-19
Frontiers | The Impact of ACE2 Polymorphisms on COVID-19 Disease: Susceptibility, Severity, and Therapy
Structural basis of human ACE2 higher binding affinity to currently circulating Omicron SARS-CoV-2 sub-variants BA.2 and BA.1.1 - ScienceDirect
Computational prediction of the effect of mutations in the receptor-binding domain on the interaction between SARS-CoV-2 and human ACE2 | Molecular Diversity
Molecular dynamic simulations reveal detailed spike-ACE2 interactions
Outsmarting SARS-CoV-2 by empowering a decoy ACE2 | Signal Transduction and Targeted Therapy
Antibody neutralization of SARS-CoV-2 through ACE2 receptor mimicry | Nature Communications
Targeting ACE2 as a treatment for COVID | LGC Standards
Synthetic α‐Helical Peptides as Potential Inhibitors of the ACE2 SARS‐CoV‐2 Interaction - Engelhardt - 2022 - ChemBioChem - Wiley Online Library
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection | European Journal of Clinical Microbiology & Infectious Diseases
Scientists uncover the structural mechanism of coronavirus receptor binding | Crick
-1.jpg "How does a SARS-CoV-2 Virion Bind to ACE2?")
How does a SARS-CoV-2 Virion Bind to ACE2?
IJMS | Free Full-Text | Characterization of Critical Determinants of ACE2–SARS CoV-2 RBD Interaction
Cells | Free Full-Text | Mechanistic Origin of Different Binding Affinities of SARS-CoV and SARS-CoV-2 Spike RBDs to Human ACE2
Molecular interaction and inhibition of SARS-CoV-2 binding to the ACE2 receptor | Nature Communications
Kobophenol A Inhibits Binding of Host ACE2 Receptor with Spike RBD Domain of SARS-CoV-2, a Lead Compound for Blocking COVID-19 | The Journal of Physical Chemistry Letters
Structural Basis for Human Receptor Recognition by SARS-CoV-2 Omicron Variant BA.1 | Journal of Virology
Engaging the spikes: heparan sulfate facilitates SARS-CoV-2 spike protein binding to ACE2 and potentiates viral infection | Signal Transduction and Targeted Therapy
Computational biophysical characterization of the SARS-CoV-2 spike protein binding with the ACE2 receptor and implications for infectivity - Computational and Structural Biotechnology Journal
